Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Not Confirmed
Not Confirmed
17-21 January, 2026
Not Confirmed
Not Confirmed
21-22 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Industry Trade Show
Not Confirmed
17-21 January, 2026
Industry Trade Show
Not Confirmed
21-22 January, 2026
Digital content

08 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/08/3201953/0/en/Arcutis-Strengthens-Board-of-Directors-with-New-Appointment-of-Amit-Munshi-and-Honors-Retirement-of-Bhaskar-Chaudhuri.html

17 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/17/3189050/0/en/FDA-Accepts-Supplemental-New-Drug-Application-for-Arcutis-ZORYVE-roflumilast-Cream-0-3-for-the-Treatment-of-Plaque-Psoriasis-in-Children-Ages-2-to-5.html

13 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/13/3187274/0/en/Arcutis-Completes-Enrollment-in-INTEGUMENT-INFANT-Phase-2-Study-Evaluating-ZORYVE-roflumilast-Cream-0-05-in-Infants-with-Atopic-Dermatitis.html

07 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/07/3183944/0/en/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

04 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/04/3180240/0/en/Arcutis-Announces-Publication-of-Positive-Long-Term-Safety-and-Efficacy-Data-of-ZORYVE-roflumilast-Foam-0-3-in-Individuals-with-Seborrheic-Dermatitis-in-American-Journal-of-Clinica.html

04 Nov 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/arcutis-taps-90210-star-power-spell-out-needs-skin-condition-patients
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE